• Publications
  • Influence
The comeback kid: TYSABRI now FDA approved for Crohn disease.
  • Karen Honey
  • Medicine
  • The Journal of clinical investigation
  • 3 March 2008
The US FDA recently approved the monoclonal antibody TYSABRI (natalizumab) for use in the treatment of adults with moderately to severely active Crohn disease (CD) who do not respond to, or do notExpand
  • 23
  • 1
Attention focuses on autism.
  • Karen Honey
  • Medicine
  • The Journal of clinical investigation
  • 1 May 2008
April was National Autism Awareness Month, an annual designation to help focus attention on autism for at least one month a year. But this year, several news stories and reports in peer-reviewedExpand
  • 4
  • 1
Rocky Mountain labs: NIAID's Montana campus.
  • Karen Honey
  • Medicine
  • The Journal of clinical investigation
  • 2 February 2009
The Division of Intramural Research (DIR) is a branch of the National Institute of Allergy and Infectious Diseases (NIAID). A fact not widely known about the DIR is that more than 20% of its researchExpand
  • 1
  • 1
Rewarding the fruits of young labor.
  • Karen Honey
  • Medicine
  • The Journal of clinical investigation
  • 2 January 2008
The recipients of the first annual New York Academy of Sciences (NYAS) Blavatnik Awards for Young Scientists were honored recently at a gala dinner in New York City. The NYAS Blavatnik Awards forExpand
  • 2
Microbicide trial screeches to a halt.
  • Karen Honey
  • Medicine
  • The Journal of clinical investigation
  • 1 May 2007
A phase III clinical trial to test the effectiveness of the HIV microbicide Ushercell was recently stopped because interim analysis indicated that the rate of infection with HIV in women using theExpand
  • 28
Drug designed to raise HDL levels falls down.
  • Karen Honey
  • Medicine
  • The Journal of clinical investigation
  • 1 February 2007
On December 2, 2006, Pfizer halted the development of torcetrapib, the drug that was once considered by the company and pharmaceutical analysts as the most promising drug in its pipeline. TheExpand
  • 12
GINA: making it safe to know what's in your genes.
  • Karen Honey
  • Medicine
  • The Journal of clinical investigation
  • 1 July 2008
President George W. Bush recently signed into law the Genetic Information Nondiscrimination Act (GINA), a bill that outlaws employers and health insurance companies from discriminating againstExpand
  • 7
Protection against malaria a real possibility.
  • Karen Honey
  • Medicine
  • The Journal of clinical investigation
  • 3 December 2007
The results of an early-stage clinical trial have brought closer the prospect of a vaccine to help protect infants and children from becoming infected with a parasite that causes the most deadly formExpand
  • 3
Good bugs, bad bugs: learning what we can from the microorganisms that colonize our bodies.
  • Karen Honey
  • Biology, Medicine
  • The Journal of clinical investigation
  • 1 December 2008
The NIH recently announced the first recipients of funding for its Human Microbiome Project. The number of microorganisms that live inside or on the body of a healthy adult human is thought to beExpand
  • 7
Translating medical science around the world.
  • Karen Honey
  • Medicine
  • The Journal of clinical investigation
  • 1 October 2007
Improving the translation of basic research into the clinic is fast becoming a priority not just in the US but also in Europe. In the US, one of the biggest initiatives to enhance translationalExpand
  • 10